- Presentations
- 4
- Markets
- 1
Cosentyx is a brand of Secukinumab marketed by Novartis Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Secukinumab
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 125 mg/5 mL injection, 150 mg/mL injection, 300 mg/2 mL injection, 75 mg/0.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cosentyx 125 mg/5 mL injectionIntravenous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Cosentyx 150 mg/mL injectionSubcutaneous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Cosentyx 300 mg/2 mL injectionSubcutaneous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
| Cosentyx 75 mg/0.5 mL injectionSubcutaneous Cold chain | Novartis Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cosentyx
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.